🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Y. Choi

University of San Diego

ORCID: 0000-0002-9107-2186

Also affiliated with University of California, San Francisco, Sanford Burnham Prebys Medical Discovery Institute, UC San Diego Health System, University of California San Diego, NovelMed Therapeutics (United States), University of California San Diego Medical Center, Moores Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576”.

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576

Advances in Hematology(2022)10.1155/2022/4450824
N/A
0.308DataRank · unranked
3 citations

Paula A. Lengerke-Diaz, Juliana Vélez Luján, Michael Y. Choi, Eider Moreno-Cortes, José Vicente Forero-Forero +7 more

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia

Leukemia(2022)10.1038/s41375-022-01543-y
N/A
0DataRank · unranked
31 citations

Laura Z. Rassenti, Michael Y. Choi, Miguel Quijada‐Álamo, Elvin Chu, George F. Widhopf +2 more

Dysregulated Spliceosome Activity Involves Increased Intron Retention Plus Upregulation and Phosphorylation of SF3B1 in Chronic Lymphocytic Leukemia

Research Square(2022)10.21203/rs.3.rs-1622375/v1
N/A
0DataRank · unranked
0 citations

Hiren Karathia, Deepak Kumar, Roberto Vera Alvarez, Paula A. Lengerke-Diaz, José Vicente Forero-Forero +15 more

Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in hepatic stellate cells

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.29.551032
N/A
0DataRank · unranked
1 citations

Chan Zhou, K. Daneshvar, Arcadia J. Kratkiewicz, Amel Ben Saad, Anja Hess +17 more

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007927
N/A
0DataRank · unranked
33 citations

Joseph Chao, H. Ma, Michael G. Hahn, Gloria Sierra, Jie Jia +13 more

Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia

Leukemia(2024)10.1038/s41375-024-02317-4
N/A
0DataRank · unranked
31 citations

Michael Y. Choi, Huan‐You Wang, Thomas J. Kipps, Richard Wong

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3815
N/A
0DataRank · unranked
116 citations

Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle M. Brander +49 more

Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102202
N/A
0DataRank · unranked
3 citations

Hiren Karathia, Deepak Kumar, Roberto Vera Alvarez, Jose Vicente Forero-Forero, Eider Moreno +15 more